BiotechTube
Home/PaxMedica/Howard Weisman
HW

Howard Weisman

Chief Executive Officer and Chairman

PaxMedica

Therapeutic Areas

NeurologyNeurodevelopmental Disorders

PaxMedica Pipeline

DrugIndicationPhase
PAX-101 (IV Suramin)Autism Spectrum Disorder (ASD)Phase 3

Leadership Team at PaxMedica

SS
Stephen Sheldon
Chief Financial Officer
DH
David H. Koschitzki
Chief Operating Officer
View full PaxMedica profile